Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs ORCHID PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA ORCHID PHARMA NATCO PHARMA/
ORCHID PHARMA
 
P/E (TTM) x 13.4 42.5 31.7% View Chart
P/BV x 3.5 7.8 45.0% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 NATCO PHARMA   ORCHID PHARMA
EQUITY SHARE DATA
    NATCO PHARMA
Mar-23
ORCHID PHARMA
Mar-23
NATCO PHARMA/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs847439 193.1%   
Low Rs502273 183.8%   
Sales per share (Unadj.) Rs148.4163.1 90.9%  
Earnings per share (Unadj.) Rs39.213.5 289.6%  
Cash flow per share (Unadj.) Rs48.227.0 178.7%  
Dividends per share (Unadj.) Rs5.500-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs267.1168.7 158.3%  
Shares outstanding (eoy) m182.4740.82 447.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.52.2 208.4%   
Avg P/E ratio x17.226.3 65.4%  
P/CF ratio (eoy) x14.013.2 106.1%  
Price / Book Value ratio x2.52.1 119.7%  
Dividend payout %14.00-   
Avg Mkt Cap Rs m123,04914,522 847.3%   
No. of employees `000NANA-   
Total wages/salary Rs m4,867654 744.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,0716,659 406.5%  
Other income Rs m1,285194 661.3%   
Total revenues Rs m28,3566,853 413.8%   
Gross profit Rs m9,1171,235 738.2%  
Depreciation Rs m1,638548 299.0%   
Interest Rs m145329 44.1%   
Profit before tax Rs m8,619552 1,560.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4660-   
Profit after tax Rs m7,153552 1,294.7%  
Gross profit margin %33.718.5 181.6%  
Effective tax rate %17.00-   
Net profit margin %26.48.3 318.5%  
BALANCE SHEET DATA
Current assets Rs m30,0035,010 598.9%   
Current liabilities Rs m6,8313,719 183.7%   
Net working cap to sales %85.619.4 441.4%  
Current ratio x4.41.3 326.0%  
Inventory Days Days6357 110.7%  
Debtors Days Days1151,180 9.8%  
Net fixed assets Rs m26,5717,242 366.9%   
Share capital Rs m365408 89.4%   
"Free" reserves Rs m48,3736,478 746.7%   
Net worth Rs m48,7386,886 707.7%   
Long term debt Rs m01,488 0.0%   
Total assets Rs m56,57412,252 461.8%  
Interest coverage x60.42.7 2,256.0%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.50.5 88.0%   
Return on assets %12.97.2 179.3%  
Return on equity %14.78.0 182.9%  
Return on capital %18.010.5 170.8%  
Exports to sales %081.9 0.0%   
Imports to sales %10.237.6 27.3%   
Exports (fob) Rs mNA5,452 0.0%   
Imports (cif) Rs m2,7722,501 110.8%   
Fx inflow Rs m17,2565,452 316.5%   
Fx outflow Rs m2,7722,726 101.7%   
Net fx Rs m14,4842,726 531.4%   
CASH FLOW
From Operations Rs m8,491183 4,630.3%  
From Investments Rs m-4,771-312 1,528.5%  
From Financial Activity Rs m-3,630312 -1,164.7%  
Net Cashflow Rs m208183 113.7%  

Share Holding

Indian Promoters % 49.7 69.8 71.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.0 18.6 134.0%  
FIIs % 13.7 4.1 331.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 50.3 30.2 166.7%  
Shareholders   207,571 36,931 562.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Natco Pharma vs Orchid Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Natco Pharma vs Orchid Pharma Share Price Performance

Period Natco Pharma Orchid Pharma S&P BSE HEALTHCARE
1-Day -1.35% 1.25% 1.23%
1-Month -2.45% -12.63% -0.70%
1-Year 74.13% 178.09% 61.90%
3-Year CAGR 5.23% -23.22% 18.18%
5-Year CAGR 11.13% 185.52% 19.80%

* Compound Annual Growth Rate

Here are more details on the Natco Pharma share price and the Orchid Pharma share price.

Moving on to shareholding structures...

The promoters of Natco Pharma hold a 49.7% stake in the company. In case of Orchid Pharma the stake stands at 69.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Natco Pharma and the shareholding pattern of Orchid Pharma.

Finally, a word on dividends...

In the most recent financial year, Natco Pharma paid a dividend of Rs 5.5 per share. This amounted to a Dividend Payout ratio of 14.0%.

Orchid Pharma paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Natco Pharma, and the dividend history of Orchid Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.